Summary
The phenotypes of alpha-1-antitrypsin have been analyzed by isoelectric focusing on polyacrylamide gels in 232 healthy Japanese blood donors and in 240 Japanese patients with chronic liver diseases: 69 with chronic active hepatitis, 122 with liver cirrhosis, 41 with hepatocellular carcinoma and 8 with primary biliary cirrhosis. The liver cirrhosis patients had a gene frequency of 0.07 forPI * M3, which was significantly higher (P<0.01) than that (0.03) in blood donors. The gene frequency of PI * M3 was significantly increased in cryptogenic liver cirrhosis (P<0.05), and there was a tendency toward an increased frequency of PI * M3 in post-transfusion groups, and in primary biliary cirrhosis. There were also tendenciestoward increased frequencies of PI * M3 in cryptogenic and post-transfusion groups of patients with chronic active hepatitis. The present study indicates that PI * M3 is a genetic or predisposing factor for chronic liver diseases, especially for cryptogenic and/or non A-non B viral chronic liver disease and also for primary biliary cirrhosis.
Similar content being viewed by others
References
Bassett ML, Bradbear RA, Kerlin P, Clark P (1986) α1-Antitrypsin phenotypes in chronic active hepatitis. J Gastroenterol Hepatol 1:207–211
Berg NO, Eriksson S (1972) Liver disease in adults with alpha1-anti-trypsin deficiency. N Engl J Med 287:1264–1267
Blenk H, Junge W (1978) Haptoglobintypen bei chronischen Leberer-krankungen. Klin Wochenschr 56:973–976
Briscoe WA, Kueppers F, Davis AL, Bearn AG (1966) A case of inherited deficiency of serum alpha1-antitrypsin associated with pulmonary emphysema. Am Rev Respir Dis 94:529–539
Carrel RW, Jeppsson JO, Laurell CB, Brennan SO, Owen MC, Vaughan L, Boswell DR (1982) Structure and variation of human α1-antitrypsin. Nature 298:329–334
Charlionet R, Martin JP, Sesboué R, Ropartz C (1976) Is there a relationship between alpha-1-antitrypsin Pi MZ phenotype and hepatoma? Biomedicine 25:125–126
Child CG 3rd, Turcotte JG (1964) Surgery and portal hypertension. In: Child CG (ed) The liver and portal hypertension. Saunders, Philadelphia, pp 1–85
Eriksson S (1964) Pulmonary emphysema and alpha1-antitrypsin deficiency. Acta Med Scand 175:197–205
Eriksson SG (1985) Liver disease in α1-antitrypsin deficiency. Aspects of incidence and prognosis. Scand J Gastroenterol 20:907–911
Eriksson S, Hägerstrand I (1974) Cirrhosis and malignant hepatoma in α1-antitrypsin deficiency. Acta Med Scand 195:451–458
Eriksson S, Carlson J, Velez R (1986) Risk of cirrhosis and primary liver cancer in alpha1-antitrypsin deficiency. N Engl J Med 314:736–739
Fagerhol MK (1968) The Pi system: genetic variants of serum α1-anti-trypsin. Ser Haematol 11:153–161
Fagerhol MK (1976) The genetics of alpha-1-antitrypsin and its implications. Postgrad Med J 52 [Suppl 2]:73–83
Fagerhol MK, Cox DW (1981) The Pi polymorphism: genetic, biochemical, and clinical aspects of human α1-antitrypsin. In: Harris H, Hirschhorn K (eds) Advances in human genetics, vol 11. Plenum Press, New York, pp 1–62
Fargion S, Klasen EC, Lalatta F, Sangalli G, Tommasini M, Fiorelli G (1981) α1-Antitrypsin in patients with hepatocellular carcinoma and chronic active hepatitis. Clin Genet 19:134–139
Ganrot PO, Laurell CB, Eriksson S (1967) Obstructive lung disease and trypsin inhibitors in α1-antitrypsin deficiency. Scand J Clin Lab Invest 19:205–208
Gedde-Dahl Jr T, Fagerhol MK, Cook PJL, Noades J (1972) Autosomal linkage between the Gm and Pi loci in man. Ann Hum Genet 35:393–399
Gedde-Dahl Jr T, Cook PJL, Fagerhol MK, Pierce JA (1975) Improved estimate of the Gm-Pi linkage. Ann Hum Genet 39:43–50
Govindarajan S, Ashcavai M, Peters RL (1981) α-1-Antitrypsin phenotypes in hepatocellular carcinoma. Hepatology 1:628–631
Hirayama C, Nakamura M, Koga S (1975) Serum haptoglobin type and liver cirrhosis. Humangenetik 28:139–146
Hodges JR, Millward-Sadler GH, Barbatis C, Wright R (1981) Heterozygous MZ alpha1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N Engl J Med 304:557–560
Kamboh MI (1985) Biochemical and genetic aspects of human serum α1-proteinase inhibitor protein. Disease Markers 3:135–154
Kramps JA, Brouwers JW, Maesen F, Dijkman JH (1981) PiMheerlen, a PiM allele resulting in very low α1-antitrypsin serum levels. Hum Genet 59:104–107
Kueppers F (1969) Identification of the heterozygous state for the α1-antitrypsin deficiency gene in man. Biochem Genet 3:283–288
Labadie H, Sesboué R, Martin JP, Beaugrand M (1985) Carcinome hépatocellulaire et phénotype de l'α1-antitrypsine. Gastroenterol Clin Biol 9:881–885
Larsson C (1978) Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z. Acta Med Scand 204:345–351
Laurell CB, Eriksson S (1963) The electrophoretic α1-globulin pattern of serum in α1-antitrypsin deficiency. Scand J Clin Lab Invest 15:132–140
Mackay IR (1983) Immunological aspects of chronic active hepatitis. Hepatology 3:724–728
Mareček Z, Hoenigová J (1970) Serum-Haptoglobintypen bei Leber-krankheiten. Experientia 26:1096–1097
McCombe PA, Clark P, Frith JA, Hammond SR, Stewart GJ, Pollard JD, McLeod JG (1985) α-1-Antitrypsin phenotypes in demyelinating disease: an association between demyelinating disease and the allele PiM3. Ann Neurol 18:514–516
Miyake K, Oka H, Oda T (1980) α1-Antitrypsin phenotypes in Japanese-classification of six M subtypes. Jinrui Idengaku Zasshi 25:183–184
Nakamura H, Ogawa A, Hisano S, Fukuma M, Tachibana N, Tsuda K (1980) A family with a new deficient of alpha 1-antitrypsin PiMnchinan-with special reference to diastase-resistant, periodic acid-schiff positive globules in the liver cells. Nippon Naika Gakkai Zasshi 69:967–974
Plaitano G, Guardascione F, Politi C (1979) L'alfa1 antitrypsina nelle cirrosi criptogenetiche. Quad Sclavo Diagn 15:165–169
Rawlings W, Moss J, Cooper HS, Hamilton SR (1974) Hepatocellular carcinoma and partial deficiency of alpha-1 antitrypsin (MZ). Ann Intern Med 81:771–773
Reintoft I, Hägerstrand IE (1979) Does the Z gene variant of alpha-1-antitrypsin predispose to hepatic carcinoma? Hum Pathol 10:419–424
Sánchez EF, Ruiz VC, Berges CL, Fermoso J (1983) Niveles de alpha1-antitrypsina en el suero de pacientes neoplásicos. Med Clin (Barc) 81:752–754
Sharp HL, Bridges RA, Krivit W, Freier EF (1969) Cirrhosis associted with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder. J Lab Clin Med 73:934–939
Talamo RC, Langley CE, Reed CE, Makino S (1973) α1-Antitrypsin deficiency: a variant with no detectable α1-antitrypsin. Science 181:70–71
Tartaglino B, Macrì G, Molino G, Furlani D, Sansalvadore F (1980) Comportamento dell' α1 antitrypsina sierica in corso di epatopatie croniche e suo significato diagnostico. Quad Sclavo Diagn 16:451–458
Vergalla J, Jones EA, Kew MC (1983) Alpha-1-antitrypsin deficiency and hepatocellular carcinoma. Determination of Pi phenotypes using iso-electric focusing. S Afr Med J 64:950–951
Vischer TL (1979) Protease inhibitors reduce mitogen induced lymphocyte stimulation. Immunology 36:811–813
Weidinger S, Jahn W, Cujnik F, Schwarzfischer F (1985) Alpha-1-antitrypsin: evidence for a fifth PI M subtype and a new deficiency allele PI*ZAugsburg. Hum Genet 71:27–29
Xu S, Guan S, Wang P, Chen F (1983) Assay of serum A1-antitrypsin activity for the diagnosis of primary hepatocellular carcinoma. Chin Med J [Engl] 96:607–610
Yuasa I, Suenaga K, Gotoh Y, Ito K, Yokoyama N, Okada K (1984) Pi(α1-antitrypsin) polymorphism in the Japanese: confirmation of PI*M4 and description of new PI variants. Hum Genet 67:209–212
Zipprich B, Giebelmann R, Tolani K, Schmidt W, Königstedt B, Scheibe E, Nilius R (1986) Haptoglobin type and liver disease. Hepatogastroenterology 33:196–198
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kishimoto, Y., Yamada, S. & Hirayama, C. An association between α1-antitrypsin phenotype and chronic liver disease. Hum Genet 84, 132–136 (1990). https://doi.org/10.1007/BF00208927
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00208927